Stenhouse Mark 4
4 · Prometheus Biosciences, Inc. · Filed May 20, 2022
Insider Transaction Report
Form 4
Stenhouse Mark
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-05-20+86,582→ 86,582 totalExercise: $29.56From: 2025-05-20Exp: 2032-05-19→ Common Stock (86,582 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest in full on the third anniversary of the grant date, subject to the Reporting Person's continued service with the Issuer on such vesting date.